Skip to content
Comparative-Effectiveness Research on Implantable Cardioverter Defibrillators episode artwork

Aug 23, 2010 14 min

Comparative-Effectiveness Research on Implantable Cardioverter Defibrillators

from Heart Matters

Host: Janet Wright, MD Guest: Mark Hlatky, MD Implantable cardioverter defibrillators, or ICDs, can be life saving for patients after myocardial infarction, but are also costly and may not be appropriate for all of the hundreds of thousands of patients who have had MI. Which subsets of patients might benefit most from ICDs, and might prophylactic use of ICDs early after MI reduce the risk of cardiac death? Dr. Mark Hlatky, professor of medicine and professor of health research and policy at Stanford University School of Medicine, weighs the comparative-effectiveness research on the efficacy of ICDs for patients early after MI, versus waiting a few months before implanting ICDs or trying other forms of therapy. Outside of implantable devices, what else can physicians do to reduce the risk of death after MI? Hosted by Dr. Janet Wright. Produced in Cooperation with

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Comparative-Effectiveness Research on Implantable Cardioverter Defibrillators

0:00 14:59

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Heart Matters?

This episode is 14 minutes long.

When was this Heart Matters episode published?

This episode was published on August 23, 2010.

Can I download this Heart Matters episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.